General
Preferred name
ISOSORBIDE
Synonyms
Devicoran ()
Isobide ()
Hydronol ()
Dianhydro-D-glucitol ()
D-Isosorbide ()
Isosorbide ()
AT-101 ()
D-Isosorbide,Dianhydro-D-glucitol ()
Ismotic ()
Isosorbida ()
1,4:3,6-dianhydro-d-glucitol ()
D-glucitol, 1,4:3,6-dianhydro- ()
NSC-40725 ()
P&D ID
PD011997
CAS
151380-60-8
28980-83-8
652-67-5
Tags
available
obsolete probe
drug
Approved by
FDA
First approval
1974
Drug Status
approved
investigational
withdrawn
Max Phase
4.0
Drug indication
Chronic lymphocytic leukemia
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
INDICATION
Indicated for the prevention and treatment of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.[label]
DESCRIPTION
Isosorbide (D-Isosorbide), an orally active vasodilating agent that can be used for the research of heart failure and angina (chest pain). Isosorbide is also an oral hyperosmotic diuretic[1][2].
PRICE
29
DESCRIPTION
Isosorbide is a vasodilator used for the prevention and treatment of angina pectoris due to coronary artery disease. It was previously used to reduce intraocular pressure. Isosorbide binds to the Bcl-2 protein and inhibits the tumor cell growth.
(Enamine Bioactive Compounds)
DESCRIPTION
Isosorbide is a heterocyclic compound that is derived from glucose, used as a diuretic.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Isosorbide (Devicoran) is a heterocyclic compound that is derived from glucose, used as a diuretic.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
17
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
Enamine Bioactive Compounds
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
NPC Screening Collection
Obsolete Compounds
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
50
Molecular Weight
146.06
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
0
Ring Count
2
Aromatic Ring Count
0
cLogP
-1.49
TPSA
58.92
Fraction CSP3
1.0
Chiral centers
4.0
Largest ring
5.0
QED
0.44
Structural alerts
1
historic compounds (Chemical Probes.org)
Obsolete
Custom attributes
(extracted from source data)
Indication
angina pectoris, coronary artery disease (CAD)
MOA
nitric oxide stimulant
ATC
C01DA08
C05AE02
Pathway
Membrane Transporter/Ion Channel
Neuronal Signaling
Target
Calcium Channel
Source data

